Mr. Wensley is the Chief Technology Officer and a co-founder of e-Nicotine Technology. He has worked for over 20 years in a wide range of industries to develop and commercialize cutting-edge technology. Mr. Wensley has been integral in the creation of four new companies spanning aerospace to scientific instruments to combination
medical products. For the past 14 years, he has focused on developing novel technologies used for the pulmonary delivery of drugs to the deep lung.Prior to e-Nicotine Technology, he was at Cypress Bioscience where he headed up development of the Staccato Nicotine product, which was a result of a spinout from Alexza Pharmaceuticals called Addicere Therapeutics, where he was a member of the founding management team. Mr. Wensley was also an early employee of Alexza Pharmaceuticals (1999 – 2009) where he led the development of the basic technology for the delivery of pharmaceuticals to the CNS by way of inhalation through the delivery of very specifically size particles that permitted the achievement of deep lung delivery and thus rapid pharmacokinetic uptake. Specifically he was the lead designer of the Electric-Multi-Dose product platform, which was the predecessor to the Staccato Nicotine product.
Mr. Wensley has B.A. in Physics from the University of California at Santa Cruz and is the inventor of 47 issued patents.